Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ocera Therapeutics Inc (NASDAQ:OCRX)

2.60
Delayed Data
As of May 24
 +0.05 / +1.96%
Today’s Change
2.00
Today|||52-Week Range
4.80
-16.67%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues8.4M85.0K341.0K133.0K
 
 
 
 
 
Depreciation And Amortization332.0K324.0K200.0K213.0K
 
 
 
 
 
 
Operating ExpensesGross Income---239.0K141.0K--
 
 
 
General Expenses27.2M12.0M24.8M26.3M
 
 
 
 
 
Research And Development21.0M3.5M14.9M16.0M
 
 
 
 
 
Total Operating Expenses27.5M12.3M25.0M26.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-19.1M-12.3M-24.7M-26.3M
 
 
 
 
 
Extraordinary Credit0.0015.0K--0.00
 
 
Extraordinary Charge-1.4M-3.1M--0.00
 
 
 
Interest Expense On Debt2.4M193.0K12.0K502.0K
 
 
 
 
 
Other Expenses27.0K0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-22.8M-15.5M-24.6M-26.7M
 
 
 
 
 
Discontinued Operations0.00-1.9M50.0K227.0K
 
 
 
 
Extraordinary Items0.00-86.0K1.1M0.00
 
 
 
Net Income-22.8M-17.4M-24.6M-26.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.1M6.1M17.5M20.1M
 
 
 
 
 
Shares To Calculate EPS Diluted2.1M6.1M17.5M20.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$10.80-$2.85-$1.34-$1.32
 
 
 
 
 
EPS Diluted-$10.80-$2.84-$1.40-$1.32